Document is current
Any future updates will be listed below
-
Authors
Minoda, Yosuke
Ihara, Eikichi
Fujimori, Nao
Nagatomo, Shuzaburo
Esaki, Mitsuru
Hata, Yoshitaka
Bai, Xiaopeng
Tanaka, Yoshimasa
Ogino, Haruei
Chinen, Takatoshi
Hu, Qingjiang
Oki, Eiji
Yamamoto, Hidetaka
Ogawa, Yoshihiro
-
Funding
Funding for this research was provided by:
The National Cancer Center Research and Development Fund (2020-A-12)
- License Information
-
More Information
Article History
Received: 26 February 2022
Accepted: 20 September 2022
First Online: 5 October 2022
Competing interests
: E.I. received lecture fees from Takeda Pharmaceutical Co., Ltd., and belongs to an endowed course supported by companies including Ono Pharmaceutical Co., Ltd., Miyarisan Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Fujifilm Medical Co., Ltd., Terumo Corporation, FANCL Corporation, Ohga Pharmacy, and Abbott Japan, LLC. E.I. received a lecture honorarium from Takeda Pharmaceutical Company. Y.O. conducted collaborative research with Fujifilm Medical Co., Ltd. and FANCL Corporation. All other authors declare no conflicts of interest associated with this study.
